Skip to content

13F-HR filed by M28 Capital Management LP

M28 Capital Management LP filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-13, with 11 holding rows worth $87,203,551.

Accession
0000902664-23-005476
Filed
2023-11-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2023

A holdings report, 11 entries on the cover page, a total value of $87,203,551 stated on the cover page (in dollars after the unit check, H1), rows summing to $87,203,551 with VALUE read as dollars as filed, 13F file number 028-21846. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
WAVE LIFE SCIENCES LTD SHSY95308105Stock7,044,500$40,505,875dollars as filed
INVIVYD INC00534A102COMMON STOCK9,248,250$15,722,025dollars as filed
ROCKET PHARMACEUTICALS INC77313F106COM523,280$10,722,007dollars as filed
SPRINGWORKS THERAPEUTICS INC85205L107COM197,700$4,570,824dollars as filed
SILENCE THERAPEUTICS PLC82686Q101ADS363,800$3,572,516dollars as filed
BRIDGEBIO PHARMA INC10806X102COM121,200$3,196,044dollars as filed
CURIS INC231269309COM421,951$2,780,657dollars as filed
PROQR THERAPEUTICS NVN71542109SHS EURO1,910,600$2,483,780dollars as filed
ARROWHEAD PHARMACEUTICALS IN04280A100COM67,400$1,811,038dollars as filed
TG THERAPEUTICS INC COM88322Q108Stock216,600$1,810,776dollars as filed
NEXIMMUNE INC65344D109COM133,442$28,009dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000902664-23-005476this filing2023-11-13acceptance time not in the bulk data set